That public offering has Vicarious Surgical selling 45 million shares of RBOT stock at a price of $1 per share. Vicarious Surgical is expecting gross proceeds of $45 million from this stock offering. The company doesn’t say what it will do with these funds.
There’s also an option for underwriters to acquire another 6.75 million shares within 30 days of the offering at the same price. Morgan Stanley & Co LLC as well as Cowen and Company, LLC are serving as joint book-running managers for the RBOT stock offering.
What This Means for RBOT Stock
A public stock offering means the total number of shares of RBOT stock is increasing. At the same time, this dilutes the stakes of investors currently holding shares. That helps explain why the stock is down today.
Adding to that is the offering price of $1 per share. That’s below the prior closing price of $1.65 per share for RBOT stock. This is also likely one of the reasons that shares are falling today.
With this news comes heavy trading of RBOT stock. As of this writing, more than 1.8 million shares have changed hands. That’s already well above its daily average trading volume of about 279,000 shares.
RBOT stock is down 41.2% as of Thursday morning.
There’s more stock market news worth reading about below!
We have all of the hottest stock market coverage that traders need to know about on Thursday! That includes everything going on with shares of Aravive (NASDAQ:ARAV) stock, Traeger (NYSE:COOK) stock and Fangdd Network (NASDAQ:DUO) stock today. You can catch up on that news with the following links!
More Stock Market News For Thursday
- Why Is Aravive (ARAV) Stock Down 58% Today?
- Why Is Traeger (COOK) Stock Up 28% Today?
- Why Is Fangdd Network (DUO) Stock Up 48% Today?
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.